Related Experiment Video
Updated: Aug 8, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Stability-Indicating RP-HPLC Determination of Acetylsalicylic Acid, Dextromethorphan Hydrobromide, Phenylephrine
Selin Atlı1, Özlem Aksu Dönmez1
1Department of Analytical Chemistry, Faculty of Arts and Sciences, Yıldız Technical University, Davutpaşa Mah. Davutpaşa Caddesi, 34220, Esenler Istanbul/TÜRKİYE.
Background:
Multi-component effervescent tablets containing acetylsalicylic acid (ASA), dextromethorphan hydrobromide (DMH), phenylephrine bitartrate (PB), and chlorpheniramine maleate (CPM) pose analytical challenges due to their complex excipient composition and moisture sensitivity. Accurate quantification of these active pharmaceutical ingredients and their related degradation products or impurities is essential for product quality and stability evaluation.
Objective:
To develop and validate a stability-indicating reversed-phase HPLC (RP-HPLC) method for the determination of ASA, DMH, PB, CPM in an effervescent tablet formulation, together with the monitoring of selected related impurities.
Methods:
Chromatographic separation was achieved on an InertSustain C8 column (150 × 4.6 mm, 5 µm) using a phosphate buffer-methanol gradient containing sodium heptane sulfonate at pH 2.0, with dual-wavelength detection at 215 and 304 nm. The method was validated per ICH Q2(R2) for specificity, linearity, accuracy, precision, and solution stability. Forced degradation studies under acid, base, oxidative, photolytic, and thermal conditions confirmed stability-indicating capability.
Results:
The method provided baseline resolution of all analytes within a single chromatographic program. Linearity (R² > 0.998 for APIs, > 0.993 for impurities), recoveries (98-102% for APIs, 90-110% for impurities), and precision (%RSD ≤ 2.0 for APIs, ≤ 5.0 for impurities) met acceptance criteria.
Conclusion:
The developed RP-HPLC method demonstrated reliable performance and can be applied for routine quality control and stability testing of the evaluated effervescent tablet formulation containing multiple active ingredients.
Highlights:
This method employs ion-pairing at pH 2.0 optimized for the effervescent matrix and dual-wavelength detection for the quantification of actives and selected impurities. Fully validated per ICH Q2(R2), it demonstrates a clear stability-indicating capability and suitability for QC and stability studies of the evaluated effervescent tablet formulation.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Clinically Relevant Drug Product Specifications: Methods of Establishment
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

